Listar por tema 

Listar por tema "liver cancer"

Mostrando ítems 1-4 de 4

    • Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Barreiro, Pablo; Gómez-Gallego, Felix; Corral, Octavio Jorge; Soriano, Vicente (Journal of Viral Hepatitis, 2022)
      Chronic hepatitis C virus (HCV) infection is major cause of decompensated cirrhosis and liver cancer. The advent of curative new antiviral therapies since year 2015 has dramatically improved the prognosis of HCV patients. ...

    • Hepatitis delta in patients hospitalized in Spain (1997-2018) 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; Ramos-Belinchón, Clara; de Mendoza, Carmen; Aguilera, Antonio; Soriano, Vicente (NLM (Medline), 2021)
      BACKGROUND: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the ...

    • Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Barreiro, Pablo; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (Alimentary Pharmacology and Therapeutics, 2023)
      Background: Chronic hepatitis B virus (HBV) infection is a major cause of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented in Spain two decades ago, and potent oral antivirals ...

    • Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades 

      Ramos-Rincón, José-Manuel; Menchi-Elanzi, Maroune; Pinargote-Celorio, Héctor; Mayoral, Asunción; González-Alcaide, Gregorio; de Mendoza, Carmen; Barreiro, Pablo; Gómez-Gallego, Felix ; Corral, Octavio Jorge ; Soriano, Vicente (AIDS, 02/2022)
      Background: The prognosis of HIV infection dramatically improved after the introduction of triple antiretroviral therapy 25 years ago. Herein, we report the impact of further improvements in HIV management since then, ...